An interventional study of Non-surgical periodontal treatment with chitosan brush and Non-surgical treatment of pre-implantitis with titanium curette in Peri-implantitis, sponsored by Hacettepe University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-09-15.
Sponsored by Hacettepe University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 55 studies in Peri-Implantitis with a site in Turkey — 16 open to participants now, 19 under way, none of them phase 3. Peri-Implantitis · Turkey.
Among the 55 studies in Peri-Implantitis with a site in Turkey, this one is the 8th largest by planned enrollment of the 26 interventional ones that give a count, is one of 8 that started in 2025, is one of 26 with no phase, reaches primary completion later than 9 of the 18 other live ones, and was the 28th registered.
324 studies on the registry are indexed under Peri-Implantitis; 89 are open to participants now.
Browse Peri-Implantitis studies →16 of the 55 studies in Peri-Implantitis with a site in Turkey are open now. Recruiting first, the newest first:
Saglik Bilimleri Universitesi · Sites in Turkey
Ages 18+ · Healthy volunteers
Kübra Hazal Bilgin · Sites in Turkey
Ages 45+ · Women only
Gazi University · Sites in Turkey
Ages 21–75 · Healthy volunteers
Gazi University · Sites in Turkey
Ages 18–75 · Healthy volunteers
Biruni University · Sites in Turkey
Ages 18+
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 50 Peri-Implantitis studies recruiting now, 28 (56%) set no upper age limit and 9 (18%) stop at 75 or younger; 7 take children under 18; 26 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
55 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 8 started in 2025.
This study's planned enrollment of 60 is above the median of 40 across 196 interventional studies indexed under Peri-Implantitis.
Median enrollment 50 across the 26 interventional studies, 87 across the 29 observational. Of the 34 that completed or were terminated, 1 (3%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 55 has an industry lead sponsor. The 10 most frequent:
Hacettepe University is the lead sponsor of 1,009 studies on the registry; 214 are open to participants now.
Hacettepe University has 3 studies filed under Peri-Implantitis — fewer than ten, so there is no comparison to draw.
8 of the studies in Peri-Implantitis with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06830200Hacettepe UniversityPeri-implantitis Treatment With Chitosan Brush | 2026-12-01 |
| NCT07907900Ankara UniversityDiagnostic Accuracy of Large Language Models for Peri-Implant Marginal Bone Loss on Panoramic Radiographs | 2026-12-31 |
| NCT07785817Medipol UniversityEvaluation of aMMP-8 and IL-1β Levels and Marginal Bone Loss Associated With Peri-Implant Mucositis and Peri-Implantitis in Postmenopausal Women | 2027-02-01 |
| NCT07797127Adiyaman UniversityEvaluation of the Effects of Routine Phase I Periodontal Therapy on Clinical Parameters and Levels of Gremlin-1, CTHRC1, and Tenascin-C in Gingival Crevicular Fluid and Peri-Implant Sulcular Fluid in Individuals With Periodontitis and Peri-Implantitis | 2027-03-01 |
| NCT07471386Gazi UniversityAdjunctive Keratinized Mucosa Augmentation in Peri-Implantitis | 2027-04-01 |
Add all 8 to your calendar (.ics) → With an account.
Among the 55 studies in Peri-Implantitis with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
In dentistry, dental implant applications for tooth loss/deficiency are prominent and provide successful long-term results in terms of functionality and aesthetics. However, peri-implant diseases such as peri-implant mucositis and peri-implantitis may develop due to biofilm accumulation around the implant. In peri-implantitis, in addition to the clinical inflammation findings seen in peri-implant mucositis, there is also progressive bone loss. This condition is to be treated with non-surgical or surgical methods. Titanium curettes, ultrasonic instruments, laser systems, and chitosan brushes are used for biofilm removal in non-surgical treatment. Chitosan is a natural polysaccharide obtained from chitin. It is biocompatible, biodegradable, and has antibacterial activity. In addition, chitosan reduces the levels of IL-1β, IL-6, and TNF-α, which also play a role in the pathogenesis of peri-implantitis, and exhibits anti-inflammatory effects on macrophages activated by lipopolysaccharide. Although many methods are used to treat peri-implantitis, successful and predictable results cannot be obtained. This study aims to examine the clinical and immunological findings and observe the changes in the non-surgical treatment of peri-implantitis using chitosan brush or titanium curette over 12 months. Sixty dental implants diagnosed with peri-implantitis clinically and radiographically at the Department of Periodontics, Faculty of Dentistry, Hacettepe University will be included in the study. Non-surgical peri-implantitis treatment of these patients will be performed using a chitosan brush (N=30, case group) or titanium curette (N=30, control group). Pre-operative and post-operative 3rd, 6th, and 12th months, clinical periodontal indices will be recorded, peri-implant crevicular fluid (PIF) will be collected, and maintenance treatment will be applied to the patients. IL-1β, TNF-α, IL-8, IL-10, and IL-17 levels in the collected PIF will be determined by the ELISA method. The effectiveness of chitosan brush and titanium curette in treating peri-implantitis will be evaluated and compared clinically and immunologically.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The implants in the chitosan brush group will be debrided with a chitosan brush dipped in sterile physiological saline solution using a rotary instrument system for 2 minutes. After mechanical treatment, the peri-implant pockets will be washed with sterile physiological saline solution. In cases with BOP+ and PD≥ 4 mm at 3 and 6 months after treatment, the treatment will be repeated in the same way as the previous one. Local infiltration anesthesia will be applied to the patients when deemed necessary. The prosthetic superstructures of the implants will not be removed for clinical examination or treatment. In cases where there is more than one implant in the same patient requiring peri-implantitis treatment, all of these implants will be included in the same treatment group.
Procedure: Non-surgical periodontal treatment with chitosan brush
The implants in the titanium curette group will be treated with titanium curettes for 2 minutes. After mechanical treatment, the peri-implant pockets will be washed with sterile physiological serum. In cases with BOP+ and PD≥ 4 mm at 3 and 6 months after treatment, the treatment will be repeated in the same way as the previous one. Local infiltration anesthesia will be applied to the patients when deemed necessary. The prosthetic superstructures of the implants will not be removed for clinical examination or treatment. In cases where there is more than one implant requiring peri-implantitis treatment in the same patient, all of these implants will be included in the same treatment group.
Device: Non-surgical treatment of pre-implantitis with titanium curette
Non-surgical treatment of pre-implantitis with chitosan brush
Description: Non-surgical treatment of pre-implantitis with titanium curette
Probing Pocket Depth
The distance between the mucosal margin and the bottom of the peri-implant pocket \[six sites (mesiobuccal, buccal, distobuccal, mesiolingual, lingual and distolingual) on each implant\]
Time frame: From the baseline to the 12th month (Baseline, 3rd, 6th, 12th months)
Radiographic Bone Level (RBL)
RBL is determined in millimeters by metrically measuring the distance from the implant shoulder to the first bone-implant contact on the radiograph. Increasing RBL indicates worse outcome
Time frame: From the baseline to the 12th month (Baseline, 6th, 12th months)
Gingival index (GI)
According to the GI system; 0: Normal gingiva 1. Mild inflammation with no edema, color change or bleeding on probing in the gingiva 2. Moderate inflammation with redness, edema and brightness in the gingiva and bleeding on probing 3. Severe inflammation with significant redness, edema, ulceration and spontaneous bleeding. Six sites (mesiobuccal, buccal, distobuccal, mesiolingual, lingual and distolingual) on each implant. The gingival index of an implant is calculated by dividing the total score of that implant by 4. Increased GI indicates worse outcome.
Time frame: From the baseline to the 12th month (Baseline, 3rd, 6th, 12th months)
Plaque Index (PI)
According to PI scores; 0: No plaque 1. Invisible film-like plaque attached to the free gingival margin and adjacent implant surface, detectable with a probe 2. Visible, moderate soft attachment within the gingival pocket or on the gingival margin and adjacent implant surface 3. Indicates the presence of dense soft attachment within the gingival pocket or on the gingival margin and adjacent implant surface. Six sites (mesiobuccal, buccal, distobuccal, mesiolingual, lingual and distolingual) were measured on each implant.The arithmetic average of 4 measurement values obtained from an implant is recorded as the PI score for that implant. Increased PI indicates worse outcome
Time frame: From the baseline to the 12th month (Baseline, 3rd, 6th, 12th months)
Bleeding on Probing
Time frame: From the baseline to the 12th month (Baseline, 3rd, 6th, 12th months)
Keratinized Mukoza Width
The distance between the keratinized mucosa margin and the mucogingival junction in the mid-buccal region of the implant
Time frame: From the baseline to the 12th month (Baseline, 3rd, 6th, 12th months)
Recession Depth
The distance between the margin of the prosthetic restoration and the keratinized mucosal marjin
Time frame: From the baseline to the 12th month (Baseline, 3rd, 6th, 12th months)
IL-1β
From PIOS
Time frame: From the baseline to the 12th month (Baseline, 3rd, 6th, 12th months)
TNF-α
From PIOS
Time frame: From the baseline to the 12th month (Baseline, 3rd, 6th, 12th months)
IL-8
From PIOS
Time frame: From the baseline to the 12th month (Baseline, 3rd, 6th, 12th months)
IL-10
From-PIOS
Time frame: From the baseline to the 12th month (Baseline, 3rd, 6th, 12th months)
IL-17
From PIOS
Time frame: From the baseline to the 12th month (Baseline, 3rd, 6th, 12th months)
Started Apr 2025 (actual). Primary completion is estimated for Dec 2026, 19 months after the start.
Of 121 non-industry interventional studies with no phase under Peri-Implantitis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 46. This study's planned 19 months is below that.
Counting every sponsor, half of 128 studies reached it within 26 months; a quarter within 12 and three quarters within 40.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.